Xiaoqi Sun, PhD
About Me
Dr. Xiaoqi (Kevin) Sun is an Assistant Professor in the Department of Immunology and Immunotherapy, the Icahn Genomics Institute (IGI), the Lipschultz Precision Immunology Institute (PrIISM), and Tisch Cancer Institute. His research group at Mount Sinai is interested in three key research areas: 1) Utilizing nanoparticle and molecular engineering to create novel approaches for immune cell reprogramming; 2) Advancing next-generation gene editing through innovations in non-viral delivery systems; 3) Employing fundamental principles of immunology and pharmaceutical sciences to develop new therapeutic strategies for cancer, infectious, and autoimmune/inflammatory diseases.
Lab website: https://www.igen-lab.com/
Selected Honors:
- 2025 DP2 New Innovator Award (NIH/NIAID)
- 2025 KL2 Career Development Award (NIH/ConduITS Institute at Mount Sinai)
- 2025 Melanoma Research Alliance Young Investigator Award
- 2022 CRS PhD Thesis Award Winner
- 2021 Rackham Predoctoral Fellowship
Language
Position
Research Topics
Anti-Tumor Therapy, Cancer, Gene Therapy, Gene editing, Immune Antagonism, Immunological Tolerance, Inflammation, Inflammatory Bowel Disease (IBD), Personalized Medicine
Multi-Disciplinary Training Areas
Cancer Biology [CAB], Development Regeneration and Stem Cells [DRS], Disease Mechanisms and Therapeutics (DMT), Genetics and Genomic Sciences [GGS], Immunology [IMM]
About Me
Dr. Xiaoqi (Kevin) Sun is an Assistant Professor in the Department of Immunology and Immunotherapy, the Icahn Genomics Institute (IGI), the Lipschultz Precision Immunology Institute (PrIISM), and Tisch Cancer Institute. His research group at Mount Sinai is interested in three key research areas: 1) Utilizing nanoparticle and molecular engineering to create novel approaches for immune cell reprogramming; 2) Advancing next-generation gene editing through innovations in non-viral delivery systems; 3) Employing fundamental principles of immunology and pharmaceutical sciences to develop new therapeutic strategies for cancer, infectious, and autoimmune/inflammatory diseases.
Lab website: https://www.igen-lab.com/
Selected Honors:
- 2025 DP2 New Innovator Award (NIH/NIAID)
- 2025 KL2 Career Development Award (NIH/ConduITS Institute at Mount Sinai)
- 2025 Melanoma Research Alliance Young Investigator Award
- 2022 CRS PhD Thesis Award Winner
- 2021 Rackham Predoctoral Fellowship
Language
Position
Research Topics
Anti-Tumor Therapy, Cancer, Gene Therapy, Gene editing, Immune Antagonism, Immunological Tolerance, Inflammation, Inflammatory Bowel Disease (IBD), Personalized Medicine
Multi-Disciplinary Training Areas
Cancer Biology [CAB], Development Regeneration and Stem Cells [DRS], Disease Mechanisms and Therapeutics (DMT), Genetics and Genomic Sciences [GGS], Immunology [IMM]
